Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Update entities : Lineage cell therapeutics, inc. save search
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
ERNA | $2.15 0.46% 4.8K
|
Information
|
| O: 3.16%
H: 0.0%
C: -0.5%
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 1.77%
H: 0.0%
C: -1.74%
business year update cell therapeutics financial results
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 1.92%
H: 1.89%
C: -1.89%
report business year update cell therapeutics financial results
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-09 (Crawled : 00:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 0.91%
H: 2.69%
C: -3.6%
business update cell therapeutics financial results
Lineage Cell Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on November 9, 2023
Published: 2023-11-01 (Crawled : 13:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 0.0%
H: 0.88%
C: -1.75%
report business update cell therapeutics financial results
Lineage Cell Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Update on August 10, 2023
Published: 2023-08-03 (Crawled : 13:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: -1.44%
H: 6.57%
C: 2.92%
report business update cell therapeutics financial results
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 9, 2023
Published: 2023-03-02 (Crawled : 14:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 0.0%
H: 2.17%
C: 0.72%
report year therapeutics financial update results
Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss
Published: 2023-02-08 (Crawled : 13:20) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: -0.69%
H: 1.4%
C: 0.7%
treatment program update
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 1.6%
H: 6.3%
C: 4.72%
therapeutics financial update results
Lineage Cell Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on November 10, 2022
Published: 2022-11-03 (Crawled : 13:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 0.0%
H: 5.38%
C: 1.54%
report therapeutics financial update results
Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-11 (Crawled : 22:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 0.64%
H: 4.46%
C: -1.27%
therapeutics update results
Lineage Cell Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
Published: 2022-08-04 (Crawled : 14:00) - biospace.com/
LCTX | $1.2 -6.98% 0.0% 1M
|
Health Technology
|
| O: 1.23%
H: 8.48%
C: 7.27%
report therapeutics update results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.